Selective Drug Targets in Parasites

Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates

Volumn , Issue , 2009, Pages 75-98

  Köhler, Peter ^a,b   Marhöfer, Richard J ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Intervet Innovation GmbH ^*  (Switzerland)

^c Intervet Innovation GmbH   (Germany)

Author keywords

Drug discovery; Parasites; Selective drug targets

Indexed keywords

EID: 84883981229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626816.ch6     Document Type: Chapter

References (60)

1. Marr, J.J. and Müller, M. (eds) (1995) Biochemistry and Molecular Biology of Parasites, Academic Press, New York.
2. Marr, J.J., Nelsen, T.W. and Komuniecki, R.W. (eds) (2003) Molecular Medical Parasitology, Academic Press, London.
3. Kohler, P. and Tielens, A.G.M. (2008) Energy metabolism, in Encyclopedia of Parasitology (ed. H. Mehlhorn), SpringerVerlag, Berlin, pp. 460-472.
4. Mertens, E., Ladror, U.S., Lee, J.A., Miretsky, A., Morris, A., Rozario, C., Kemp, R.G. and Muller, M. (1998) The pyrophosphate-dependent phosphofructokinase of the protist, Trichomonas vaginalis, and the evolutionary relationships of protist phosphofructokinases. Journal of Molecular Evolution, 47, 739-750.
5. Deng, Z., Huang, M., Singh, K., Albach, R.A., Latshaw, S.P., Chang, K.-P. and Kemp, R.G. (1998) Cloning and expression of the gene for the active PPi-dependent phosphofructokinase of Entamoeba histolytica. The Biochemical Journal, 329, 659-664.
6. Li, Z. and Phillips, N.F. (1997) Involvement and identification of a lysine in the PPi-site of pyrophosphate-dependent phosphofructokinase from Giardia lamblia. Biochimie, 79, 221-227.
7. Chi, A.S., Deng, Z., Albach, R.A. and Kemp, R.G. (2001) The two phosphofructokinase gene products of Entamoeba histolytica. The Journal of Biological Chemistry, 276, 19974-19981.
8. Moore, S.A., Ron, S., Ronimus, R.S., Roberson, R.S. and Morgan, H.W. (2002) The Structure of a pyrophosphate-dependent phosphofructokinase from the Lyme disease spirochete Borrelia burgdorferi. Structure (London, England: 1993), 10, 659-671.
9. Mansour, T.E. (ed.) (2002) Chemotherapeutic Targets in Parasites, Cambridge University Press, pp. 143-145.
10. Ghosh, S., Chan, J.M., Lea, C.R., Meints, G.A., Lewis, J.C., Tovian, Z.S., Flessner, R.M. et al. (2004) Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo. Journal of Medicinal Chemistry, 47, 175-187.
11. Hiltpold, A., Thomas, R.M. and Kohler, P. (1999) Purification and characterization of recombinant pyruvate phosphate dikinase from Giardia. Molecular and Biochemical Parasitology, 104, 157-169.
12. Slamovits, C.H., Patrick, J. and Keeling, P.J. (2006) Pyruvate-phosphate dikinase of oxymonads and Parabasalia and the evolution of pyrophosphate-dependent glycolysis in anaerobic eukaryotes. Eukaryotic Cell, 5, 148-154.
13. Cosenza, L.W., Bringaud, F., Baltz, T. and Vellieux, F.M.D. (2002) The 3.0 Å resolution crystal structure of glycosomal pyruvate phosphate dikinase from Trypanosoma brucei. Journal of Molecular Biology, 318, 1417-1432.
14. Nakanishi, T., Nakatsu, T., Matsuoka, M., Sakata, K. and Kato, H. (2005) Crystal structures of pyruvate phosphate dikinase from maize revealed an alternative conformation in the swiveling-domain motion. Biochemistry, 44, 1136-1144.
15. Stephen, P., Vijayan, R., Bhat, A., Subbarao, A.N. and Bamezai, R.N.K. (2008) Molecular modeling on pyruvate phosphate dikinase of Entamoeba histolytica and in silico virtual screening for novel inhibitors. Journal of Computer-Aided Molecular Design, 22, 647-660.
16. Hrdy, I. and Muller, M. (1995) Primary structure and eubacterial relationship of pyruvate: ferredoxin oxidoreductase of the amitochondriate eukaryote Trichomonas vaginalis. Journal of Molecular Evolution, 41, 388-396.
17. Rodriguez, M.A., Hidalgo, M.E., Sánchez, T. and Orozco, E. (1996) Cloning and characterization of the Entamoeba histolytica pyruvate: ferredoxin oxidoreductase gene. Molecular and Biochemical Parasitology, 78, 273-277.
18. Townson, S.M., Upcrof, J.A. and Upcroft, P. (1996) Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Molecular and Biochemical Parasitology, 79, 183-193.
19. Cavazza, C., Contreras-Martel, C., Pieulle, L., Chabriere, E., Hatchikian, E.C. and Fontecilla-Camps, J.C. (2006) Flexibility of thiamine diphosphate revealed by kinetic crystallographic studies of the reaction of pyruvate-ferredoxin oxidoreductase with pyruvate. Structure (London, England: 1993), 14, 217-224.
20. Upcroft, P. and Upcroft, J.A. (2001) Drug targets and mechanisms of resistance in the anaerobic protozoa. Clinical Microbiology Reviews, 14, 150-164.
21. Ali, V. and Nozaki, T. (2007) Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by 'amitochondriate' protozoan parasites. Clinical Microbiology Reviews, 20, 164-187.
22. Sato, D., Yamagata, W., Harada, S. and Nozaki, T. (2008) Kinetic characterization of methionine gamma-lyases from the enteric protozoan parasite Entamoeba histolytica against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis. FEBS Journal, 275, 548-560.
23. Sato, D., Yamagata, W., Kamei, K., Nozaki, T. and Harada, S. (2006) Expression, purification and crystallization of L-methionine gamma-lyase 2 from Entamoeba histolytica. Acta Crystallographica, Section F: Structure, Biology and Crystallography Communications, 62, 1034-1036.
24. Kudou, D., Misaki, S., Yamashita, M., Tamura, T., Takakura, T., Yoshioka, T., Yagi, S. et al. (2007) Structure of the antitumour enzyme L-methionine gamma-lyase from Pseudomonas putida at 1.8 A resolution. Journal of Biochemistry, 141, 535-544.
25. Inoue, K., Noji, M. and Sait, K. (1999) Determination of the sites required for the allosteric inhibition of serine acetyltrans-ferase by L-cysteine in plants. European Journal of Biochemistry, 266, 220-227.
26. Westrop, G.D., Goodall, G., Mottram, J.C. and Coombs, G.H. (2006) Cysteine biosynthesis in Trichomonas vaginalis involves cysteine synthase utilizing O-phosphoserine. The Journal of Biological Chemistry, 281, 25062-25075.
27. Oda, Y., Mino, K., Ishikawa, K. and Ataka, M. (2005) Three-dimensional structure of a new enzyme, O-phosphoserine sulfhydrylase, involved in L-cysteine biosynthesis by a hyperthermophilic archaeon, Aeropyrum pernix K1, at 2.0 Å resolution. Journal of Molecular Biology, 351, 334-344.
28. Kai, Y., Kashiwagi, T., Ishikawa, K., Ziyatdinov, M.K., Redkina, E.I., Kiriukhin, M.Y., Gusyatiner, M.M. et al. (2006) Engineering of Escherichia coli L-serine O-acetyltransferase on the basis of crystal structure: desensitization to feedback inhibition by L-cysteine. Protein Engin Design Select, 19, 163-167.
29. Agarwal, S.M., Jain, R., Bhattacharya, A. and Azam, A. (2008) Inhibitors of Escherichia coli serine acetyltransferase block proliferation of Entamoeba histolytica trophozoites. International Journal for Parasitology, 38, 137-141.
30. Zocher, G., Wiesand, U. and Schulz, G.E. (2007) High resolution structure and catalysis of O-acetylserine sulfhydrylase isozyme B from Escherichia coli. FEBS Journal, 274, 5382-5389.
31. Chattopadhyay, A., Meier, M., Ivaninskii, S. and Burkhard, P. (2007) Structure, mechanism, and conformational dynamics of O-acetylserine sulfhydrylase from Salmonella typhimurium: Comparison of A and B Isozymes. Biochemistry, 46, 8315-8330.
32. Schnell, R., Oehlmann, W., Singh, M. and Schneider, G. (2007) Structural insights into catalysis and inhibition of O-acetylserine sulfhydrylase from Mycobacterium tuberculosis. Crystal structures of the enzyme a-aminoacrylate intermediate and an enzyme inhibitor complex. The Journal of Biological Chemistry, 282, 23473-23481.
33. Krishna, C., Jain, R., Kashav, T., Wadhwa, D., Alam, N. and Gourinath, S. (2007) Crystallization and preliminary crystallographic analysis of cysteine synthase from Entamoeba histolytica. Acta Crystallographica, Section F: Structure, Biology and Crystallography Communications, 63, 512-515.
34. Comini, M., Menge, U., Wissing, J. and Flohe, L. (2005) Trypanothione synthesis in Crithidia revisited. The Journal of Biological Chemistry, 280, 6850-6860.
35. Bond, C.S., Zhan, Y., Berriman, M., Cunningham, M.L., Fairlamb, A.H. and Hunter, W.N. (1999) Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure (London, England: 1993), 7, 81-89.
36. Saravanamuthu, A., Vickers, T.J., Bond, C.S., Peterson, M.R., Hunter, W.N. and Fairlamb, A.H. (2004) Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. The Journal of Biological Chemistry, 279, 29493-29500.
37. Krieger, S., Schwarz, W., Ariyanayagam, M.R., Fairlamb, A.H., Krauth-Siegel, R.L. and Clayton, C. (2000) Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Molecular Microbiology, 35, 542-552.
38. Martyn, D.C., Jones, D.C., Fairlamb, A.H. and Clardy, J. (2007) High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity. Bioorganic & Medicinal Chemistry Letters, 17, 1280-1283.
39. Chaudhuri, M., Ott, R.D. and Hill, G.C. (2006) Trypanosome alternative oxidase: from molecule to function. Trends in Parasitology, 22, 484-491.
40. Suzuki, T., Nihei, C., Yabu, Y., Hashimoto, T., Suzuk, M., Yoshida, A., Nagai, K. et al. (2004) Molecular cloning and characterization of Trypanosoma vivax alternative oxidase (AOX) gene, a target of the trypanocide ascofuranone. Parasitology International, 53, 235-245.
41. Yabu, Y., Suzuki, T., Nihei, C., Minagawa, N., Hosokaw, T., Nagai, K., Kita, K. et al. (2006) Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol. Parasitology International, 55, 39-43.
42. Ott, R., Chibale, K., Anderson, S., Chipeleme, A., Chaudhuri, M., Guerrah, A., Colowick, N. and Hill, G.C. (2006) Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration. Acta Tropica, 100, 172-184.
43. Campbell, S.A., Richards, T.A., Mui, E.J., Samuel, B.U., Coggins, J.R., McLeod, R. and Roberts, C.W. (2004) A complete shikimate pathway in Toxoplasma gondii: an ancient eukaryotic innovation. International Journal for Parasitology, 34, 5-13.
44. Ehammer, H., Rauch, G., Prem, A., Kappes, B. and Macheroux, P. (2007) Conservation of NADPH utilization by chorismate synthase and its implications for the evolution of the shikimate pathway. Molecular Microbiology, 65, 1249-1257.
45. Quevillon-Cheruel, S., Leulliot, N., Meyer, Ph., Graille, M., Bremang, M., Blondeau, K., Sorel, I. et al. (2003) Crystal structure of the bifunctional chorismate synthase from Saccharomyces cerevisiae. The Journal of Biological Chemistry, 279, 619-625.
46. Dias, M.V.B., Borges, J.C., Ely, F., Pereira, J.H., Canduri, F., Ramos, C.H.I., Frazzon, J. et al. (2006) Structure of chorismate synthase from Mycobacterium tuberculosis. Journal of Structural Biology, 154, 130-143.
47. Dias, M.V.B., Ely, F., Palma, M.S., de Azevedo, W.F. Jr, Basso, L.A. and Santos, D.S. (2007) Chorismate synthase: An attractive target for drug development against orphan diseases. Current Drug Targets, 8, 437-444.
48. Arora, N., Chari, U.V.N.M., Barnerjee, A.K. and Murty, U.S.N. (2007) A computational approach to explore Plasmodium falciparum 3D7 chorismate synthase. International Journal of Genomics and Proteomics, 3.
49. Henriksson, L.M., Bjårkelid, C., Mowbray, S.L. and Unge, T. (2006) The 1.9 A resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target. Biological Crystallography, 62, 807-813.
50. Yajima, S., Hara, K., Iino, D., Sasaki, Y., Kuzuyama, T., Ohsawa, K. and Seto, H. (2007) Structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin. Acta Crystallographica, Section F: Structure, Biology and Crystallography Communications, 63, 466-470.
51. Singh, N., Avery, M.A. and McCurdy, C.R. (2007) Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulations. Journal of Computer-Aided Molecular Design, 21, 511-522.
52. Wiesner, J. and Jomaa, H. (2007) Isoprenoid biosynthesis of the apicoplast as drug target. Current Drug Targets, 8, 3-13.
53. Wiesner, J., Ortmann, R., Jomaa, H. and Schlitzer, M. (2007) Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity. Archiv der Pharmazie, 340, 661-666.
54. Kita, K., Shiomi, K. and Omura, S. (2007) Advances in drug discovery and biochemical studies. Trends in Parasitology, 23, 223-229.
55. Matsumoto, J., Sakamoto, K., Shinjyo, N., Kido, Y., Yamamoto, N., Yagi, K., Miyoshi, H. et al. (2008) Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis. Antimicrobial Agents and Chemotherapy, 52, 164-170.
56. Raymond, V. and Sattelle, D.B. (2002) Novel animal-health drug targets from ligand-gated chloride channels. Nature Reviews. Drug Discovery, 1, 427-436.
57. Kohler, P. (2001) The biochemical basis of anthelmintic action and resistance. International Journal for Parasitology, 31, 336-345.
58. Wolstenholme, A.J. and Rogers, A.T. (2005) Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology, 131, S85-S95.
59. Zhao, X., Yeh, J.Z., Salgado, V.L. and Narahashi, T. (2004) Fipronil is a potent open channel blocker of glutamate-activated chloride channels in cockroach neurons. The Journal of Pharmacology and Experimental Therapeutics, 310, 192-201.
60. Kaminsky, R., Ducray, P., Jung, M., Clover, R., Rufener, L., Bouvier, J., Schorderet Weber, S. et al. (2008) A new class of anthelmintics effective against drug-resistant nematodes. Nature, 452, 176-180.